[DPHARMA] QoQ Cumulative Quarter Result on 30-Sep-2016 [#3]

Stock
[DPHARMA] DUOPHARMA BIOTECH BERHAD
Announcement Date
21-Nov-2016
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2016
Quarter
30-Sep-2016 [#3]
Profit Trend
QoQ- 52.82%
YoY- -19.51%
Quarter Report
Latest QR
Upcoming QR
DPHARMA's Result
DPHARMA's Financial Summary
View:
Show?
Cumulative Result
30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 CAGR
Revenue 240,355 120,994 312,940 238,907 158,605 79,470 270,680 -7.62%
PBT 24,764 11,176 31,479 25,180 17,664 9,941 49,755 -37.22%
Tax -5,559 -2,558 -4,653 -7,185 -5,895 -2,113 0 -
NP 19,205 8,618 26,826 17,995 11,769 7,828 49,755 -47.01%
-
NP to SH 19,217 8,618 27,115 18,867 12,346 7,843 38,775 -37.40%
-
Tax Rate 22.45% 22.89% 14.78% 28.53% 33.37% 21.26% 0.00% -
Total Cost 221,150 112,376 286,114 220,912 146,836 71,642 220,925 0.06%
-
Net Worth 463,071 463,071 454,703 451,913 446,334 457,492 270,177 43.26%
Dividend
30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 CAGR
Div 6,973 - 18,132 - 6,973 - 15,843 -42.16%
Div Payout % 36.29% - 66.87% - 56.49% - 40.86% -
Equity
30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 CAGR
Net Worth 463,071 463,071 454,703 451,913 446,334 457,492 270,177 43.26%
NOSH 278,959 278,959 278,959 278,959 278,959 278,959 278,959 0.00%
Ratio Analysis
30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 CAGR
NP Margin 7.99% 7.12% 8.57% 7.53% 7.42% 9.85% 18.38% -
ROE 4.15% 1.86% 5.96% 4.17% 2.77% 1.71% 14.35% -
Per Share
30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 CAGR
RPS 86.16 43.37 112.18 85.64 56.86 28.49 162.30 -34.46%
EPS 6.88 3.43 9.62 6.45 4.22 2.81 19.17 -49.52%
DPS 2.50 0.00 6.50 0.00 2.50 0.00 9.50 -58.96%
NAPS 1.66 1.66 1.63 1.62 1.60 1.64 1.62 1.64%
Adjusted Per Share Value based on latest NOSH - 278,959
30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 CAGR
RPS 24.99 12.58 32.53 24.84 16.49 8.26 28.14 -7.61%
EPS 2.00 0.90 2.82 1.96 1.28 0.82 4.03 -37.34%
DPS 0.72 0.00 1.88 0.00 0.72 0.00 1.65 -42.49%
NAPS 0.4814 0.4814 0.4727 0.4698 0.464 0.4756 0.2809 43.25%
Price Multiplier on Financial Quarter End Date
30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 CAGR
Date 30/06/17 31/03/17 30/12/16 30/09/16 30/06/16 31/03/16 31/12/15 -
Price 2.25 2.31 1.98 2.06 2.04 2.55 2.62 -
P/RPS 2.61 5.33 1.76 2.41 3.59 8.95 1.61 38.03%
P/EPS 32.66 74.77 20.37 30.46 46.09 90.70 11.27 103.39%
EY 3.06 1.34 4.91 3.28 2.17 1.10 8.87 -50.84%
DY 1.11 0.00 3.28 0.00 1.23 0.00 3.63 -54.64%
P/NAPS 1.36 1.39 1.21 1.27 1.28 1.55 1.62 -11.01%
Price Multiplier on Announcement Date
30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 CAGR
Date 25/08/17 22/05/17 24/02/17 21/11/16 22/08/16 18/05/16 23/02/16 -
Price 2.03 2.32 2.23 2.10 2.14 2.40 2.61 -
P/RPS 2.36 5.35 1.99 2.45 3.76 8.42 1.61 29.06%
P/EPS 29.47 75.10 22.94 31.05 48.35 85.36 11.23 90.36%
EY 3.39 1.33 4.36 3.22 2.07 1.17 8.91 -47.52%
DY 1.23 0.00 2.91 0.00 1.17 0.00 3.64 -51.51%
P/NAPS 1.22 1.40 1.37 1.30 1.34 1.46 1.61 -16.89%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment